Cellular Distribution and Gene Expression Pattern of Metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in Oral Lesions as Markers for Molecular Pathology

References

• Silverman S. Oral Cancer. 5th ed. Lewiston, NY: PMPH-USA; 2003.
   Google Scholar
• Chambers M, Jacob R. How carcinogens ‘cause’ cancer. Tex Dent J 1994;111:13–17.
   Google Scholar
• Wenghoefer M, Pesch B, Harth V, Broede P, Fronhoffs S, Landt O, et al. “Association between head and neck cancer and microsomal epoxide hydrolase genotypes.” Arch Toxicol 2003;77(1):37–44.
   PubMed Web of Science ®Google Scholar
• Pindborg JJ. Oral Cancer and Precancer. Bristol, UK: John Wright & Sons; 1980.
   Google Scholar
• Bouquot J. Epidemiology. In Pathology of the Head and Neck D. Gnepp, Ed. New York, NY: Churchill Livingstone 1987;263–314.
   Google Scholar
• Bouquot JE. Reviewing oral leukoplakia: clinical concepts for the 1990s. J Am Dent Assoc 1939 1991;122(6):80–82.
   Google Scholar
• Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235–243.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Dommisch D, Reich R, Martini M, Allam JP, et al. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int. J. Oral Maxillofac. Surg 2008;37(7):660–663.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. (Eds). SEER Cancer Statistics Review, 1975–2013. Bethesda, MD: National Cancer Institute; 2016. Available from: http://seer.cancer.gov/csr/1975_2013/
   Google Scholar
• Axéll T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol. Revy. Suppl 1976;36:1–103.
   PubMedGoogle Scholar
• Bouquot JE, Gundlach KK. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg. Oral Med. Oral Pathol 1986;62(3):284–291.
   Google Scholar
• Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol 2007;36(10):575–580.
   Google Scholar
• Sciubba JJ. Oral leukoplakia. Crit. Rev. Oral Biol. Med. Off. Publ. Am. Assoc. Oral Biol 1995;6(2):147–160.
   Google Scholar
• Dayan D, Bodner L, Hammel I, Wolman M. Histochemical characterization of collagen fibers in fibrous overgrowth (irritation fibroma) of the oral mucosa: effect of age and duration of lesion. Arch. Gerontol. Geriatr 1994;18(1):53–57.
   PubMed Web of Science ®Google Scholar
• Winter J, Pantelis A, Reich R, Jepsen S, Allam JP, Novak N, et al. Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression. Cancer Invest 2011;29(7):478–484.
   PubMed Web of Science ®Google Scholar
• Kim ST, Kim HJ, Park IS, Park SW, Kim WH, Kim YM. Chronic, reactive conditions of the oral cavity simulating mucosal carcinomas: CT and MR imaging findings with pathologic correlation in five patients. Clin. Imaging 2005;29(6):406–411.
   PubMed Web of Science ®Google Scholar
• AbdulMajeed AA, Farah CS. Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review. Clinical Medicine Insights Oncology 2013;7:279–290.
   PubMedGoogle Scholar
• Saintigny P, Zhang L, Fan Y-H, El-Naggar AK, Papadimitrakopoulou V, Feng L, et al. Gene Expression Profiling Predicts the Development of Oral Cancer. Cancer Prevention Research (Philadelphia, Pa.) 2011;4(2):218–229.
   PubMed Web of Science ®Google Scholar
• Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol 2001;33(7):637–668.
   PubMed Web of Science ®Google Scholar
• Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 Proteins. Curr. Mol. Med 2013;13(1):24–57.
   PubMed Web of Science ®Google Scholar
• Heizmann CW, Fritz G, Schäfer BW. S100 proteins: structure, functions and pathology. Front. Biosci. J. Virtual Libr 2002;7:d1356–1368.
   PubMed Web of Science ®Google Scholar
• Donato R. Intracellular and extracellular roles of S100 protein. Microsc. Res. Tech 2003;60(6):540–551.
   PubMed Web of Science ®Google Scholar
• Chen H, Xu C, Jin Q, Liu Z. S100 protein family in human cancer. Am. J. Cancer Res 2014;4(2):89–115.
   PubMed Web of Science ®Google Scholar
• Ravasi T, Hsu K, Goyette J, Schroder K, Yang Z, Rahimi F, et al. Probing the S100 protein family through genomic and functional analysis. Genomics 2004;84(1):10–22.
   PubMed Web of Science ®Google Scholar
• Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J. Biol. Chem 2006;281(2):677–680.
   PubMed Web of Science ®Google Scholar
• Rosty C, Ueki T, Argani P, Jansen MC, Yeo CJ, Cameron JL, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol 2002;160(1):45–50.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Zheng XZ, Wang XH, Xuan XY, Wang F, Li SS. S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity. Mol. Biol. Rep 2012;39(1):199–208.
   PubMed Web of Science ®Google Scholar
• Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan M, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. U. S. A 2006;103(40):14825–14830.
   PubMed Web of Science ®Google Scholar
• Jenkinson SR, Barraclough R, West CR, Rudland PS. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br. J. Cancer 2004;90(1):253–262.
   PubMed Web of Science ®Google Scholar
• Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, et al. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. J. Cell Sci 2007;120 Pt(12):2053–2065.
   PubMed Web of Science ®Google Scholar
• Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, Lin SC, et al. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res 2011;71(5):1912–1923.
   PubMed Web of Science ®Google Scholar
• Natarajan J, Hunter K, Mutalik VS, Radhakrishnan R. Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma. Journal of Applied Oral Science 2014;22(5):426–433.
   PubMed Web of Science ®Google Scholar
• Hu F-W, Lee S-S, Yang L-C, Tsai C-H, Wang T-H, Chou M-Y, et al. Knockdown of S100A4 impairs arecoline-induced invasiveness of oral squamous cell carcinomas. Oral Oncology 2015;51(7):690–697.
   PubMed Web of Science ®Google Scholar
• Hunter MJ, Chazin WJ. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem 1998;273(20):12427–12435.
   PubMed Web of Science ®Google Scholar
• Korndörfer IP, Brueckner F, Skerra A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol 2007;370(5):887–898.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol 2009;625(1–3):73–83.
   PubMed Web of Science ®Google Scholar
• Kong JP, Ding F, Zhou CN, Wang XQ, Miao XP, Wu M, et al. Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World J. Gastroenterol. WJG 2004;10(8):1093–1097.
   PubMed Web of Science ®Google Scholar
• Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr. Cancer Drug Targets 2008;8(4):243–252.
   PubMed Web of Science ®Google Scholar
• Khammanivong A, Wang C, Sorenson S, Ross KF, Herzberg MC. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma. PloS One 2013;8(7):e69395.
   PubMed Web of Science ®Google Scholar
• Harris TM, Du P, Kawachi N, Belbin TJ, Wang Y, Schlecht NF, et al. Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome—associated proteins. Archives of Pathology & Laboratory Medicine 2015;139(4):494–507.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29(9):e45.
   PubMed Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem 2009;55(4):611–622.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis M, Najafi T, Deschner J, Allam JP, Novak N, Reich R, Martini M, Bergé S, Fischer HP, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod 2010;110(3):351–356.
   PubMed Web of Science ®Google Scholar
• Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009;45(6):526–530.
   PubMed Web of Science ®Google Scholar
• Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, et al. High α-defensin and S100A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation. J. Craniofac. Surg 2011;22(1):100–104.
   PubMed Web of Science ®Google Scholar
• Silva EJ, Argyris PP, Zou X, Ross KF, Herzberg MC. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells. Int. J. Biochem. Cell Biol 2014;55:279–287.
   PubMed Web of Science ®Google Scholar
• Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000;67(8):923–936.
   PubMed Web of Science ®Google Scholar
• Wang J, Cai Y, Xu H, Zhao J, Xu XY, Han YL, et al. Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer. Cell Res 2004;14(1):46–53.
   PubMed Web of Science ®Google Scholar
• Choi DK, Li ZJ, Chang IK, Yeo MK, Kim JM, Sohn KC, et al. Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro. Arch. Dermatol. Res 2014;306(5):489–496.
   PubMed Web of Science ®Google Scholar